ArticleCureus2026
Oral Baclofen Toxicity in a Pediatric Patient Managed Without Invasive Intervention: A Case Report and Literature Review.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Baclofen is utilized for the management of spasticity associated with neurological disorders such as cerebral palsy, multiple sclerosis, and spinal cord injuries. It acts as an agonist for the gamma-aminobutyric acid (GABA)-B receptor. Although baclofen proves to be effective, it presents a significant risk of toxicity and withdrawal symptoms, particularly among pediatric patients, where pharmacokinetics and clinical presentations may diverge from those observed in adults. Furthermore, baclofen is generally not detected in standard toxicology screening, underscoring the need for heightened clinical awareness. We report a case involving a five-year-old boy who inadvertently received a toxic dose of baclofen. He was admitted to the Pediatric Intensive Care Unit via the pediatric emergency room, exhibiting signs and symptoms of convulsions, drowsiness, and bradycardia. The convulsions were managed with intravenous diazepam, and the child made a full recovery within 24 hours with appropriate supportive care. This case report emphasizes that prompt intervention in the case of baclofen overdose prevented the need for invasive procedures such as mechanical ventilation and hemodialysis. Effective supportive therapy yields favorable outcomes, given that there has been no hypoxic or ischemic injury before receiving medical assistance. This literature review focuses on oral baclofen toxicity, without delving deeply into the topics of intrathecal baclofen toxicity and withdrawal. This case contributes to the expanding literature on pediatric baclofen toxicity and highlights the potential for favorable outcomes with prompt intervention.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.